Long-Term Lamotrigine Adjunctive to Antipsychotic Monotherapy in Schizophrenia: Further Evidence

Wassef AA Dott SG Harris A Brown A O'Boyle M Meyer WJ III , and others. Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. J Clin Psychopharmacol 2000;20:357–61.

Dursun SM McIntosh D Milliken H. Clozapine plus lamotrigine in treatment-resistant schizophrenia. Arch Gen Psychiatry 1999;56:950.

Dursun SM Deakin JF . Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: A naturalistic case-series outcome study. J Psychopharmacol 2001;15:297–301.

Saba G Dumortier G Kalalou K Benadhira R Degrassat K Glikman J , and others. Lamotrigine–clozapine combination in refractory schizophrenia: Three cases. J Neuropsychiatry Clin Neurosci 2002;14:86.

Meltzer HY Alphs L Green AI Altamura AC Anand R Bertoldi A , and others. Clozapine treatment for suicidality in schizophrenia International Suicide Prevention Trial (InterSePT). Arch general Psychiatry 2003;60: 82–91.

Goff DC Coyle JT . The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001;158:1367–77.

Anand A Charney DS Oren DA Berman RM Hu XS Cappiello A , and others. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 2000;57:270–6.

Olney JW Newcomer JW Farber NB . Is NMDA receptor hypofunction in schizophrenia associated with a primary hyperglutamatergic state? Arch Gen Psychiatry 2002;59:466–8.

Moghaddam B. Stress activation of glutamate neurotransmission in the prefrontal cortex: Implications for dopamine-associated psychiatric disorders. Biol Psychiatry 2002;51:775–87.